Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (291-300 of 743) with videos related to

Pageof 75
Sort By:
EMBO Molecular Medicine|October 9, 2023
NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5Selina Gurri, Beat Siegenthaler, Michael Cangkrama, et al.
Cancers|June 2, 2021
Who's Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal MelanomaSandra N Freiberger, Patrick Turko, Martin Hüllner, et al.
Transplantation|January 16, 2004
Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipientsGalya Dragieva, Jürg Hafner, Reinhard Dummer, et al.
Cancer|July 11, 2008
Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 studyAxel Hauschild, Reinhard Dummer, Selma Ugurel, et al.
Clinical and Translational Medicine|July 8, 2022
Identification and characterization of novel CD274 (PD-L1) regulating microRNAs and their functional relevance in melanomaChristoforos K Vaxevanis, Michael Friedrich, Sandy Uta Tretbar, et al.
International Journal of Cancer|April 12, 2002
Loss of single HLA class I allospecificities in melanoma cells due to selective genomic abbreviationsRalf Geertsen, Roland Böni, Rainer Blasczyk, et al.
European Journal of Cancer (Oxford, England : 1990)|February 17, 2018
Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanomaPauline Tétu, Joanna Mangana, Reinhard Dummer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2018
Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic MelanomaFlorentia Dimitriou, Alexandra V Matter, Joanna Mangana, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 29, 2021
Correction: Establishing standardized immune phenotyping of metastatic melanoma by digital pathologyBettina Sobottka, Marta Nowak, Anja Laura Frei, et al.
Journal of Clinical Medicine|August 23, 2020
Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in MelanomaMaria-Filothei Lazaridou, Chiara Massa, Diana Handke, et al.
Pageof 75

Showing results (291-300 of 743) with videos related to

Sort By:
Pageof 75
EMBO Molecular Medicine|October 9, 2023
NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5Selina Gurri, Beat Siegenthaler, Michael Cangkrama, et al.
Cancers|June 2, 2021
Who's Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal MelanomaSandra N Freiberger, Patrick Turko, Martin Hüllner, et al.
Transplantation|January 16, 2004
Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipientsGalya Dragieva, Jürg Hafner, Reinhard Dummer, et al.
Cancer|July 11, 2008
Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 studyAxel Hauschild, Reinhard Dummer, Selma Ugurel, et al.
Clinical and Translational Medicine|July 8, 2022
Identification and characterization of novel CD274 (PD-L1) regulating microRNAs and their functional relevance in melanomaChristoforos K Vaxevanis, Michael Friedrich, Sandy Uta Tretbar, et al.
International Journal of Cancer|April 12, 2002
Loss of single HLA class I allospecificities in melanoma cells due to selective genomic abbreviationsRalf Geertsen, Roland Böni, Rainer Blasczyk, et al.
European Journal of Cancer (Oxford, England : 1990)|February 17, 2018
Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanomaPauline Tétu, Joanna Mangana, Reinhard Dummer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2018
Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic MelanomaFlorentia Dimitriou, Alexandra V Matter, Joanna Mangana, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 29, 2021
Correction: Establishing standardized immune phenotyping of metastatic melanoma by digital pathologyBettina Sobottka, Marta Nowak, Anja Laura Frei, et al.
Journal of Clinical Medicine|August 23, 2020
Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in MelanomaMaria-Filothei Lazaridou, Chiara Massa, Diana Handke, et al.
Pageof 75